Peter Sacripanti
CEO
- CEO of SHP Legal Services, where he leads the development and delivery of innovative, client-focused legal solutions, guiding organizations through complex legal and business challenges.
- 40 years of legal experience, including serving as Chairman of McDermott Will & Emery, he has advised Fortune 50 companies such as Exxon, Honeywell, and Apple on high-stakes legal and business matters.
- Specializes in addressing intricate challenges across industries, with a focus on executive-level problem-solving and innovative strategy development.
About
Peter Sacripanti serves as the CEO of SHP Legal Services, where he leads the organization’s efforts to provide innovative, client-focused legal solutions. Drawing on decades of experience as a trusted advisor to Fortune 50 companies such as Exxon, Honeywell, and Apple, Peter oversees the creation of tailored strategies designed to address complex legal and business challenges. Known for his ability to unite cross-functional teams, he drives SHPLS’s vision of empowering clients with practical and forward-thinking solutions.
Peter’s leadership philosophy centers on creativity, adaptability, and a commitment to customized strategies. He believes no two clients should ever receive the same approach; an ethos demonstrated by his innovative use of bankruptcy statutes to secure the survival of a Fortune 50 company facing existential threats. With a reputation for addressing intricate business challenges that defy off-the-shelf solutions, Peter continues to set a standard for ingenuity and excellence in the legal industry.
Before launching SHP Legal Services, Peter served as Chairman of McDermott Will & Emery, where he advised on high-stakes legal and business matters across industries and geographies. He began his legal career as a federal prosecutor in the Attorney General’s Honors Program and later took on leadership roles as a public company director, serving on compensation, audit, and transactions committees. Peter is a Trustee Fellow of Fordham University and a member of the Board of Advisors at Columbia University Medical Center.